2016 annual financial data
Ovid Therapeutics 2016 Operating margin
Ovid Therapeutics 2016 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -22,535,000 USD and net income was -22,414,000 USD.
Operating cash flow was -17,801,971 USD.
Get free Ovid Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -22,535,000 USD
- Net income
- -22,414,000 USD
- Operating cash flow
- -17,801,971 USD